News

media

Oct 5, 2023

Drug Discovery World

Nobel-connected startup Shasqi deepens J&J partnership on CAPAC platform

press

Oct 4, 2023

Press release

Shasqi to Expand Existing Research Collaboration to Advance Targeted Cancer Treatment

press

Aug 2, 2023

Press Release

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team

media

Jul 5, 2023

Nature Biotech

Clicked' drugs: researchers prove the remarkable chemistry in humans

press

Jun 28, 2023

Press Release

Shasqi Publishes Data on Systemic Antigen Targeting Approach Using Click Chemistry to Activate MMAE in Tumors

publication

Jun 23, 2023

ACS Central Science

Click chemistry selectively activates an auristatin protodrug with either intratumoral or systemic tumor-targeting agents

conference

Jun 4, 2023

2023 - ISHAS

A Hyaluronate Derivative Biopolymer Enables Activation of Protodrugs at Tumors in Animals and Humans Using Click Chemistry

press

Jun 1, 2023

Press Release

Shasqi Announces Research Collaboration to Transform Targeted Cancer Treatment

media

Jun 1, 2023

SF Business Times

Click chemistry company Shasqi just struck a deal with Johnson & Johnson

conference

Apr 23, 2023

2023 - AACR - SQ3370 Poster

SQ3370, a doxorubicin-based click chemistry therapeutic, promotes a shift from an immunosuppressive towards a T-cell permissive tumor microenvironment in patients

conference

Apr 23, 2023

2023 - AACR - SQP22 Poster

A click chemistry-activated auristatin protodrug (SQP22) demonstrates potency and safety with antibody and intratumoral tumor-targeting agents

conference

Apr 16, 2023

2023 AACR

CAPAC a modular platform that can improve the safety and efficacy of existing cancer therapies